Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Fulgent Genetics, Inc. Common Stock (FLGT)

Services-medical Laboratories

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

4399 SANTA ANITA AVE
EL MONTE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/29/2016

Market Cap

711,518,000

Shares Outstanding

29,630,000

Weighted SO

29,633,057

Total Employees

N/A

Upcoming Earnings

08/02/2024

Similar Tickers

NVTA --.--%

ILMN --.--%

TTOO --.--%

A --.--%

MTD --.--%

WAT --.--%

DHR --.--%

TMO --.--%

CRL --.--%

Beta

1.3720

Last Div

0.0000

Range

18.91-34.64

Chg

-0.0250

Avg Vol

184354

Mkt Cap

711518000

Exch

NASDAQ

Country

US

Phone

626 350 0537

DCF Diff

-35.7703

DCF

59.0720

Div Yield

0.0000

P/S

2.4476

EV Multiple

-14.4660

P/FV

0.6241

Div Yield %

0.0000

P/E

-4.3252

PEG

-0.1586

Payout

0.0000

Current Ratio

5.2686

Quick Ratio

5.2686

Cash Ratio

0.8595

DSO

79.9985

DIO

0.0000

Op Cycle

79.9985

DPO

39.6428

CCC

40.3557

Gross Margin

0.3706

Op Margin

-0.2455

Pretax Margin

-0.5632

Net Margin

-0.5622

Eff Tax Rate

-0.0428

ROA

-0.1326

ROE

-0.1404

ROCE

-0.0617

NI/EBT

0.9982

EBT/EBIT

2.2938

EBIT/Rev

-0.2455

Debt Ratio

0.0046

D/E

0.0050

LT Debt/Cap

0.0022

Total Debt/Cap

0.0050

Int Coverage

-1.9545

CF/Debt

6.4598

Equity Multi

1.0880

Rec Turnover

4.5626

Pay Turnover

9.2072

Inv Turnover

999999.9999

FA Turnover

2.8347

Asset Turnover

0.2359

OCF/Share

1.2201

FCF/Share

0.3886

Cash/Share

10.3564

OCF/Sales

0.1263

FCF/OCF

0.3185

CF Coverage

6.4598

ST Coverage

11.5050

CapEx Coverage

1.4673

Div&CapEx Cov

1.4673

P/BV

0.6241

P/B

0.6241

P/S

2.4476

P/E

-4.3252

P/FCF

60.8395

P/OCF

19.2477

P/CF

19.2477

PEG

-0.1586

P/S

2.4476

EV Multiple

-14.4660

P/FV

0.6241

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 15, 23:41 Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jul 01, 01:00 Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 10, 01:00 Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 03, 01:00 Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm GlobeNewswire Inc. May 30, 21:55 INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Tempus AI Inc. (NASDAQ: TEM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm GlobeNewswire Inc. May 30, 21:48 INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of EchoStar Corporation (NASDAQ: SATS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm Benzinga May 25, 01:19 FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

Revenue Product Segmentation